Bio-Rad Laboratories (BIO) Total Debt Growth (3y) (2012 - 2026)
Powered by 
Analysis
Bio-Rad Laboratories (BIO) Total Debt Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 5.73% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 9.22% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 14.36% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | -3.82% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | -9.77% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | -17.29% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 10.20% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | 22.44% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | - |
| 10 | Bruker | 8.30 Bn | 8.09 Bn | 416.00 Mn | 13.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.20% |
| Mar 31, 2026 | 10.20% |
| Dec 31, 2025 | 0.17% |
| Sep 30, 2025 | 0.17% |
| Jun 30, 2025 | 0.14% |
| Mar 31, 2025 | 0.13% |
| Dec 31, 2024 | 377.99% |
| Sep 30, 2024 | 359.48% |
| Jun 30, 2024 | 357.47% |
| Mar 31, 2024 | 356.19% |
| Dec 31, 2023 | 339.84% |
| Sep 30, 2023 | 39.80% |
| Jun 30, 2023 | 39.81% |
| Mar 31, 2023 | 39.82% |
| Dec 31, 2022 | 39.67% |
| Sep 30, 2022 | 39.67% |
| Jun 30, 2022 | 39.67% |
| Mar 31, 2022 | 39.68% |
| Dec 31, 2021 | -70.74% |
| Sep 30, 2021 | -69.59% |